{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:40:49Z","timestamp":1781739649676,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ebiom.2023.104463","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T19:38:09Z","timestamp":1676057889000},"page":"104463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine"],"prefix":"10.1016","volume":"89","author":[{"given":"Kyle L.","family":"O'Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5354-9270","authenticated-orcid":false,"given":"Chad S.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-9587","authenticated-orcid":false,"given":"Andrea","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104463_bib1","series-title":"Fields virology","author":"Feldmann","year":"2013"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104463_bib2","doi-asserted-by":"crossref","first-page":"e00095","DOI":"10.1128\/MMBR.00095-19","article-title":"A\u00a0forgotten episode of marburg virus disease: belgrade, Yugoslavia, 1967","volume":"84","author":"Ristanovic","year":"2020","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ebiom.2023.104463_bib3","first-page":"3","article-title":"Filovirus research: how it began","volume":"411","author":"Slenczka","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104463_bib4","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/JVI.00069-06","article-title":"Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola","volume":"80","author":"Towner","year":"2006","journal-title":"J\u00a0Virol"},{"issue":"26","key":"10.1016\/j.ebiom.2023.104463_bib5","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1056\/NEJMc2120183","article-title":"Detection of marburg virus disease in Guinea","volume":"386","author":"Koundouno","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2023.104463_bib6","doi-asserted-by":"crossref","first-page":"o1797","DOI":"10.1136\/bmj.o1797","article-title":"Ghana declares its first outbreak of Marburg virus disease after two deaths","volume":"378","author":"Hussain","year":"2022","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104463_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/trstmh\/trv024","article-title":"Mapping the zoonotic niche of Marburg virus disease in Africa","volume":"109","author":"Pigott","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2023.104463_bib8","series-title":"Prioritizing diseases for research and development in emergency contexts","year":"2021"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104463_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/pathogens10091092","article-title":"Vesicular stomatitis virus: from agricultural pathogen to vaccine vector","volume":"10","author":"Liu","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ebiom.2023.104463_bib10","series-title":"First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response","year":"2019"},{"key":"10.1016\/j.ebiom.2023.104463_bib11","series-title":"First vaccine to protect against Ebola","year":"2019"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104463_bib12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2023.104463_bib13","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3389\/fimmu.2018.03071","article-title":"Protection against marburg virus using a recombinant VSV-vaccine depends on T and B cell activation","volume":"9","author":"Marzi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104463_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.774026","article-title":"Single dose of a VSV-based vaccine rapidly protects macaques from marburg virus disease","volume":"12","author":"Marzi","year":"2021","journal-title":"Front Immunol"},{"issue":"9520","key":"10.1016\/j.ebiom.2023.104463_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104463_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/srep39214","article-title":"A\u00a0hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever","volume":"6","author":"Marzi","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104463_bib17","first-page":"493","article-title":"A\u00a0simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"J\u00a0Epidemiol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104463_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4269\/ajtmh.18-0937","article-title":"Gamma irradiation as an effective method for inactivation of emerging viral pathogens","volume":"100","author":"Feldmann","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2023.104463_bib19","doi-asserted-by":"crossref","first-page":"e0337921","DOI":"10.1128\/mbio.03379-21","article-title":"Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a vesicular stomatitis virus-based vaccine","volume":"13","author":"Furuyama","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2023.104463_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fimmu.2019.01025","article-title":"Knowns and unknowns of assaying antibody-dependent cell-mediated cytotoxicity against HIV-1","volume":"10","author":"Lewis","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104463_bib22","series-title":"Immunobiology handbook","year":"2022"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104463_bib23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104463_bib24","doi-asserted-by":"crossref","first-page":"e94355","DOI":"10.1371\/journal.pone.0094355","article-title":"Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates","volume":"9","author":"Mire","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2023.104463_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ebiom.2019.09.055","article-title":"Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge","volume":"49","author":"Marzi","year":"2019","journal-title":"eBioMedicine"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104463_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.vaccine.2020.11.042","article-title":"Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials","volume":"39","author":"Dulin","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104463_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/jiz364","article-title":"Survivors of Ebola virus disease develop polyfunctional antibody responses","volume":"221","author":"Gunn","year":"2020","journal-title":"J\u00a0Infect Dis"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104463_bib28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"Agnandji","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104463_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3201\/eid2102.141649","article-title":"Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104463_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00001-0","article-title":"Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques","author":"Marzi","year":"2023","journal-title":"Lancet Microbe"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104463_bib31","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S2666-5247(20)30198-1","article-title":"Estimation of the correlates of protection of the rVSVDeltaG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2\/3 clinical trials","volume":"2","author":"Grais","year":"2021","journal-title":"Lancet Microbe"},{"issue":"6249","key":"10.1016\/j.ebiom.2023.104463_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2023.104463_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.857481","article-title":"Complement-mediated neutralisation identified in Ebola virus disease survivor plasma: implications for protection and pathogenesis","volume":"13","author":"Mellors","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104463_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A\u00a0role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104463_bib35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104463_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2021.03.009","article-title":"A\u00a0Fc engineering approach to define functional humoral correlates of immunity against Ebola virus","volume":"54","author":"Gunn","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104463_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","article-title":"A\u00a0two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates","volume":"25","author":"Bornholdt","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"6277","key":"10.1016\/j.ebiom.2023.104463_bib38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104463_bib39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.molmed.2016.09.002","article-title":"Modulating antibody functionality in infectious disease and vaccination","volume":"22","author":"Gunn","year":"2016","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104463_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","article-title":"Antibody-mediated protection against Ebola virus","volume":"19","author":"Saphire","year":"2018","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104463_bib41","doi-asserted-by":"crossref","first-page":"e00597","DOI":"10.1128\/mBio.00597-19","article-title":"Antiviral innate responses induced by VSV-EBOV vaccination contribute to rapid protection","volume":"10","author":"Menicucci","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2023.104463_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.coviro.2021.10.007","article-title":"Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity","volume":"51","author":"Pinski","year":"2021","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104463_bib43","doi-asserted-by":"crossref","first-page":"e1010805","DOI":"10.1371\/journal.ppat.1010805","article-title":"An introduction to the Marburg virus vaccine consortium, MARVAC","volume":"18","author":"Cross","year":"2022","journal-title":"PLoS Pathog"},{"issue":"7563","key":"10.1016\/j.ebiom.2023.104463_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature14594","article-title":"Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa","volume":"524","author":"Carroll","year":"2015","journal-title":"Nature"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:22:38Z","timestamp":1762456958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"alternative-id":["S2352396423000282"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104463","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.09.17.508396","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104463"}}